Your browser doesn't support javascript.
loading
Associations between illicit drug use and coronary angiographic findings in patients with acute coronary syndrome.
Léquipar, Antoine; Singh, Manveer; El Bèze, Nathan; Lafont, Alexandre; Gall, Emmanuel; Guiraud-Chaumeil, Paul; Picard, Fabien; Alizadeh, Charly; Henry, Patrick; Dillinger, Jean-Guillaume.
Afiliação
  • Léquipar A; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • Singh M; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • El Bèze N; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • Lafont A; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • Gall E; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • Guiraud-Chaumeil P; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • Picard F; Service de Cardiologie, hôpital Cochin Port-Royal, AP-HP, centre - université Paris-Cité, 75014 Paris, France.
  • Alizadeh C; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France.
  • Henry P; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
  • Dillinger JG; Department of Cardiology, Assistance publique des Hôpitaux de Paris (AP-HP), université Paris-Cité, University Hospital of Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisière, 75010 Paris, France; MIRACL.ai Laboratory, Multimodality
Arch Cardiovasc Dis ; 2024 Jul 30.
Article em En | MEDLINE | ID: mdl-39122613
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arch Cardiovasc Dis Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arch Cardiovasc Dis Ano de publicação: 2024 Tipo de documento: Article